About AION Biosystems
AION Biosystems is a private company based in Lowell, Massachusetts. It has reported $10,274,737 raised in four offerings on Form D since April 2024. Its chief executive is Samara Barend.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 29, 2020 | Apr 11, 2024 | $4,325,000fully sold | 20 | $216K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| May 17, 2023 | Apr 11, 2024 | $2,350,000of $3.0M target | 11 | $213K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Apr 1, 2024 | Apr 11, 2024 | $2,499,899of $5.0M target | 1 | $2.4M | EquityRule 506(b) | Form D ↗ |
| Dec 23, 2022 | Apr 27, 2023 | $1,099,838of $3.0M target | 10 | $109K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $10,274,737 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on AION Biosystems's Form D filed Apr 11, 2024.
SB
Samara Barend
Chief Executive Officer and director
DB
David Blechman
Director
AQ
Alan Quasha
Director
TC
Todd O'Connell
Director
TW
Tom Wilson
Director
PC
Peter Costantino
Director
Earlier filings also listed Richard Miller (director, last listed Apr 2023) and Ray Hood (director, last listed Apr 2023).